Literature DB >> 3058017

Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.

G S Hall1, C Myles, K J Pratt, J A Washington.   

Abstract

Cilofungin (LY121019) is an antifungal agent that interferes with beta-glucan synthesis in the cells walls of fungi. The activity of this agent against 256 clinical isolates of yeasts was determined. It was found to be very active in vitro against Candida albicans (MIC for 90% of isolates [MIC90], less than or equal to 0.31 microgram/ml; minimal fungicidal concentration for 90% of isolates [MFC90], less than or equal to 0.31 micrograms/ml) and C. tropicalis (MIC90, less than or equal to 0.31 microgram/ml; MFC90, less than or equal to 0.31 microgram/ml) and moderately active against Torulopsis glabrata (MIC90 and MFC90, less than or equal to 20 micrograms/ml). All C. parapsilosis, Cryptococcus, and Saccharomyces cerevisiae strains were resistant. The activity of cilofungin was affected by medium and inoculum size. Antibiotic medium no. 3 was used as the standard medium. Isolates of C. albicans and C. tropicalis demonstrated a paradoxical effect in Sabouraud dextrose broth and yeast nitrogen base broth in that growth was partially inhibited at MICs equivalent to those in antibiotic medium no. 3, but growth continued, in many instances, throughout all concentrations tested. There was decreased activity of cilofungin with inocula greater than 10(5) CFU/ml. The temperature and duration of incubation did not affect its activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058017      PMCID: PMC175862          DOI: 10.1128/AAC.32.9.1331

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Cell wall composition of the mycelial and blastospore forms of Candida albicans.

Authors:  F W Chattaway; M R Holmes; A J Barlow
Journal:  J Gen Microbiol       Date:  1968-05

2.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 3.  Synthesis of the yeast cell wall and its regulation.

Authors:  E Cabib; R Roberts; B Bowers
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

4.  On the mode of action of a new antifungal antibiotic, aculeacin A: inhibition of cell wall synthesis in Saccharomyces cerevisiae.

Authors:  J Mizoguchi; T Saito; K Mizuno; K Hayano
Journal:  J Antibiot (Tokyo)       Date:  1977-04       Impact factor: 2.649

5.  Anti-Candida activity of polyoxin: example of peptide transport in yeasts.

Authors:  R J Mehta; W D Kingsbury; J Valenta; P Actor
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

6.  Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.

Authors:  N H Georgopapadakou; B A Dix; S A Smith; J Freudenberger; P T Funke
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

7.  Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Authors:  J N Galgiant; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Synthesis and biological activity of tripeptidyl polyoxins as antifungal agents.

Authors:  F Naider; P Shenbagamurthi; A S Steinfeld; H A Smith; C Boney; J M Becker
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

9.  Polyoxin D inhibits growth of zoopathogenic fungi.

Authors:  J M Becker; N L Covert; P Shenbagamurthi; A S Steinfeld; F Naider
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study.

Authors:  A Cassone; R E Mason; D Kerridge
Journal:  Sabouraudia       Date:  1981-06
View more
  21 in total

1.  Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.

Authors:  G M González; R Tijerina; L K Najvar; R Bocanegra; M Luther; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Treatment of murine disseminated candidiasis with L-743,872.

Authors:  J R Graybill; L K Najvar; M F Luther; A W Fothergill
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 3.  Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.

Authors:  Marion Aruanno; Emmanouil Glampedakis; Frédéric Lamoth
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

4.  W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase.

Authors:  J Tang; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.

Authors:  Veronika Loiko; Johannes Wagener
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

6.  Evaluation of a murine model of hepatic candidiasis.

Authors:  G T Cole; K T Lynn; K R Seshan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

7.  Comparison of cilofungin and amphotericin B for therapy of murine candidiasis.

Authors:  K R Smith; K M Lank; C G Cobbs; G A Cloud; W E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

8.  Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.

Authors:  N Khardori; H Nguyen; L C Stephens; L Kalvakuntla; B Rosenbaum; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.

Authors:  D W Denning; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

10.  In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.

Authors:  K R Smith; K M Lank; W E Dismukes; C G Cobbs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.